I'm wondering if I should continue my Abiraterone for 12 months (to Nov. 2021) even though PSA has not dropped to undetectable. I've done 8 months now. Or should I roll over to chemo sooner than that?
My MO says I am ADT/hormone-resistant. I started Abiraterone (Zytiga) in Nov 2020. My PSA did not go to undetectable. My PSAs from Feb 2021-June 2021 have been bouncing up and down in 0.26 to 0.36 range, with the only bright spot a drop in PSA in May 2021 to 0.26. MO and I then decided to continue Abiraterone for 6 more months rather than original plan to switch to Apalutamide in May 2021 if PSA got undetectable (it didn't). See my profile.
So I'm currently on track to finish Abiraterone for 12 months in Nov 2021, then reassess. MO said likely chemo with Abraxane and Carboplatin in Nov 2021 if my PSAs don't improve. I see him on 27 July for lab tests and discussion.
I'm Gleason 9 with micrometastatic PC. MO confirmed previously that STATISTICALLY I'd likely live only another couple years at this rate. Of course I'm thinking I can beat those odds.
Your perspectives? Should I stay on Abiraterone and hope for a PSA drop? Or start chemo sooner? Other treatment ideas for this ADT-resistant patient?